Skip to main content

Advertisement

SpringerLink
Log in

Long-Term Infliximab Treatment for Behçet's Disease

  • LETTERS
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. PP Sfikakis PG Theodossiadis CG Katsiari P Kaklamanis NN Markomichelakis (2001) ArticleTitleEffect of infliximab on sight-threatening panuveitis in Behçet's disease Lancet 358 295–296 Occurrence Handle11498218 Occurrence Handle10.1016/S0140-6736(01)05497-6 Occurrence Handle1:CAS:528:DC%2BD3MXlslCjsLg%3D

    Article  PubMed  CAS  Google Scholar 

  2. A Joseph D Raj HS Dua PT Powell PC Lanyon RJ Powell (2003) ArticleTitleInfliximab in the treatment of refractory posterior uveitis Ophthalmology 110 1449–1453 Occurrence Handle12867408 Occurrence Handle10.1016/S0161-6420(03)00406-8

    Article  PubMed  Google Scholar 

  3. EW Lindstedt GS Baarsma RW Kuijpers PM van Hagen (2005) ArticleTitleAnti-TNF-alpha therapy for sight threatening uveitis Br J Ophthalmol 89 533–536 Occurrence Handle15834077 Occurrence Handle10.1136/bjo.2003.037192 Occurrence Handle1:STN:280:DC%2BD2M7pvFGnsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. S Ohno S Nakamura S Hori et al. (2004) ArticleTitleEfficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis J Rheumatol 31 1362–1368 Occurrence Handle15229958 Occurrence Handle1:CAS:528:DC%2BD2cXmtlSlt7o%3D

    PubMed  CAS  Google Scholar 

  5. I Tugal-Tutkun A Mudun M Urgancioglu et al. (2005) ArticleTitleEfficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial Arthritis Rheum 52 2478–2484 Occurrence Handle16052571 Occurrence Handle10.1002/art.21231 Occurrence Handle1:CAS:528:DC%2BD2MXpslGht7s%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan

    Mitsuko Takamoto & Jiro Numaga

  2. Department of Ophthalmology, University of Tokyo Hospital, Tokyo, Japan

    Toshikatsu Kaburaki

  3. Department of Ophthalmology, Tokyo Koseinenkin Hospital, Tokyo, Japan

    Yujiro Fujino

  4. Department of Ophthalmology, Saitama Red Cross Hospital, Saitama, Japan

    Hidetoshi Kawashima

Authors
  1. Mitsuko Takamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshikatsu Kaburaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiro Numaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yujiro Fujino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hidetoshi Kawashima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuko Takamoto.

About this article

Cite this article

Takamoto, M., Kaburaki, T., Numaga, J. et al. Long-Term Infliximab Treatment for Behçet's Disease. Jpn J Ophthalmol 51, 239–240 (2007). https://doi.org/10.1007/s10384-006-0424-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-006-0424-z

Key words

Search

Navigation